Article
Neutrophils cause critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatment
2021-05-20
Abstract excerpt
<h4>Background</h4> Despite recent development of vaccines and monoclonal antibodies to prevent SARS-CoV-2 infection, treatment of critically ill COVID-19 patients remains an important goal. In principle, genome-wide association studies (GWAS) could shortcut the clinical evidence needed to repurpose drugs - the use of an existing drug for a new indication. However, it has been shown that the genes found in GWA stu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b92d0a83-7e44-5049-84de-0049e10394da
- DOI
- 10.1101/2021.05.18.21256584
